Outset Medical annual r&d spending
2018
2019
2020
2021
2022
2023
2024
2025
Outset Medical R&D Spending Growth & History (OM)
Outset Medical's r&d spending was $21.2M for fiscal 2025.
View full Outset Medical company overviewOutset Medical annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $21.2M | −$17.2M | −44.70% |
| 2024 | 2024-12-31 | $38.4M | −$18.9M | −33.00% |
| 2023 | 2023-12-31 | $57.3M | $8.5M | +17.30% |
| 2022 | 2022-12-31 | $48.9M | $12.1M | +32.97% |
| 2021 | 2021-12-31 | $36.7M | $7.9M | +27.35% |
| 2020 | 2020-12-31 | $28.9M | $5.5M | +23.68% |
| 2019 | 2019-12-31 | $23.3M | $411,000 | +1.79% |
| 2018 | 2018-12-31 | $22.9M | — | — |
Outset Medical quarterly r&d spending
Q3.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $5.5M | $161,000 | +3.04% |
| Q1 2026 | 2026-03-31 | $5.6M | $103,000 | +1.87% |
| Q4 2025 | 2025-12-31 | $5.1M | −$2.8M | −35.92% |
| Q3 2025 | 2025-09-30 | $5.4M | −$2.8M | −33.95% |
| Q2 2025 | 2025-06-30 | $5.3M | −$4.4M | −45.66% |
| Q1 2025 | 2025-03-31 | $5.5M | −$7.1M | −56.35% |
| Q4 2024 | 2024-12-31 | $7.9M | −$4.6M | −37.05% |
| Q3 2024 | 2024-09-30 | $8.1M | −$7.9M | −49.37% |
| Q2 2024 | 2024-06-30 | $9.7M | −$5.2M | −34.70% |
| Q1 2024 | 2024-03-31 | $12.6M | −$1.2M | −8.40% |
| Q4 2023 | 2023-12-31 | $12.5M | $1.1M | +9.51% |
| Q3 2023 | 2023-09-30 | $16.1M | $3.0M | +23.10% |
| Q2 2023 | 2023-06-30 | $14.9M | $1.4M | +10.24% |
| Q1 2023 | 2023-03-31 | $13.8M | $3.0M | +27.35% |
| Q4 2022 | 2022-12-31 | $11.4M | $34,000 | +0.30% |
| Q3 2022 | 2022-09-30 | $13.1M | $3.3M | +34.23% |
| Q2 2022 | 2022-06-30 | $13.5M | $5.5M | +68.34% |
| Q1 2022 | 2022-03-31 | $10.8M | $3.3M | +43.08% |
| Q4 2021 | 2021-12-31 | $11.4M | $3.6M | +46.58% |
| Q3 2021 | 2021-09-30 | $9.7M | $554,000 | +6.04% |
| Q2 2021 | 2021-06-30 | $8.0M | $2.0M | +32.69% |
| Q1 2021 | 2021-03-31 | $7.6M | $1.7M | +29.67% |
| Q4 2020 | 2020-12-31 | $7.8M | — | — |
| Q3 2020 | 2020-09-30 | $9.2M | $3.5M | +60.74% |
| Q2 2020 | 2020-06-30 | $6.1M | — | — |
| Q1 2020 | 2020-03-31 | $5.8M | — | — |
| Q3 2019 | 2019-09-30 | $5.7M | — | — |
Outset Medical r&d spending trends
Over the last five fiscal years, Outset Medical's r&d spending decreased from $28.9M to $21.2M, a change of −$7.6M. The latest reported quarter, Q2 2026, shows $5.5M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Outset Medical source filings ↗